The aim of the study was to assess constant potential levels (CP level) in patients with vibration disease (VD) in combination with metabolic disorders. Methods. Measurements were taken in three gorups: Group I (n = 94) - patients with VD, Group II (n = 42) - patients with VD and metabolic syndrome (MS), Group III (n = 31) - patients with VD and Type 2 diabetes (DM2), Group IV (n = 14) - patients with DM2 and V (n = 50) - reference group. Data were analyzed using Shapiro-Wilk, Mann-Whitney tests and discriminant analysis. Results. In groups I-IV, the percentage of individuals with altered neuroenergetic activity was higher than in the experimental group (p = 0.001; 0.003; 0.01; 0.009, respectively). CP level in group I prevailed in the central, in group II - in the left central, right temporal, in group III - in the left central, central, in group IV - in the right frontal, central, and left parietal leads when compared with group V at p < 0.01. CP level decrease in the anterior cortex (frontal, temporal: 16.6 (15-18) mV, 14.7 (12-17) mV, 17.6 (16-20) mV respectively), and its amplification in the posterior (Central, parietal: 20.4 (16-25) mV, 18.2 (14-20) mV, 23.3 (17-28) mV respectively) at p < 0.01 was diagnosed in patients of groups II-IV. As a result of discriminative analysis, two signs were identified in groups I and III: the values of CP level indicators in the left temporal and right central leads. Conclusions. Disorders of neuroenergy exchange in patients with VD in combination with MS and DM2 are manifested by an increase in CP level in the centrotemporal areas, with DM2- in the frontal-central-parietal areas. The signs of neuroenergetic mapping in patients with VD, associated with the fact of DM2 presence as a concomitant pathology are: an increase in the CP level in the right central and its decrease in the left temporal leads.

中文翻译：

---

振动病合并代谢性疾病患者的恒定电位分布

该研究的目的是评估振动疾病 (VD) 合并代谢紊乱患者的恒定电位水平 (CP 水平)。方法。测量分为三个组：I 组 (n = 94) - VD 患者，II 组 (n = 42) - VD 和代谢综合征 (MS) 患者，III 组 (n = 31) - VD 和类型患者2 型糖尿病 (DM2)，IV 组 (n = 14) - DM2 和 V 患者 (n = 50) - 参考组。使用 Shapiro-Wilk、Mann-Whitney 检验和判别分析对数据进行分析。结果。在 I-IV 组中，神经能量活动改变的个体百分比高于实验组（分别为 p = 0.001；0.003；0.01；0.009）。I组的CP水平在中央占优势，II组 - 左侧中央，右侧颞，III组 - 左侧中央，中央，在组 IV - 与组 V 相比​​，在右额叶、中央和左顶叶导联中 p < 0.01。前皮层 CP 水平降低（额叶、颞叶：分别为 16.6 (15-18) mV、14.7 (12-17) mV、17.6 (16-20) mV），其在后皮层（中央、顶叶：20.4）的放大(16-25) mV、18.2 (14-20) mV、23.3 (17-28) mV，p < 0.01 在组 II-IV 的患者中被诊断出来。作为判别分析的结果，在 I 组和 III 组中确定了两个迹象：左侧颞侧和右侧中央导联中 CP 水平指标的值。结论。VD 合并 MS 和 DM2 患者的神经能量交换障碍表现为中央颞区 CP 水平升高，而 DM2- 在额叶 - 中央 - 顶叶区。